Feng Gang, Wood Kathryn J, Bushell Andrew
Transplantation Research Immunology Group, Nuffield Department of Surgery, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Methods Mol Biol. 2011;677:281-301. doi: 10.1007/978-1-60761-869-0_20.
IFN-γ was originally characterized as a proinflammatory cytokine with T helper type 1 inducing activity, but it is now clear that it also has important immunoregulatory functions. Regulatory T cells play an important role in models of autoimmunity, GVHD, and transplantation, and offer potential as a cellular therapy. In rodent models, in vivo-generated CD25(+)CD4(+) T cells can prevent allograft rejection, but therapeutic exploitation of Treg will more likely depend on protocols that allow the generation or selection of Treg ex vivo. The experiments described in this chapter will show that alloantigen-reactive Treg can be generated/expanded ex vivo using IFN-γ, a cytokine more usually associated with allograft rejection. Although IFN-γ production has hitherto been generally regarded as nonpermissive for allograft survival, we believe this paradoxical "good-bad" role for IFN-γ may reflect an important physiological negative feedback loop.
干扰素-γ最初被表征为一种具有1型辅助性T细胞诱导活性的促炎细胞因子,但现在很清楚它也具有重要的免疫调节功能。调节性T细胞在自身免疫、移植物抗宿主病和移植模型中发挥重要作用,并具有作为细胞疗法的潜力。在啮齿动物模型中,体内产生的CD25(+)CD4(+) T细胞可以预防同种异体移植排斥,但调节性T细胞的治疗应用更可能依赖于允许在体外产生或选择调节性T细胞的方案。本章所述的实验将表明,同种异体抗原反应性调节性T细胞可以使用干扰素-γ在体外产生/扩增,干扰素-γ是一种通常与同种异体移植排斥相关的细胞因子。尽管迄今为止,干扰素-γ的产生通常被认为不利于同种异体移植存活,但我们认为干扰素-γ这种矛盾的“好坏”作用可能反映了一种重要的生理负反馈回路。